BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 27473135)

  • 1. Effects of hormone therapy on brain structure: A randomized controlled trial.
    Kantarci K; Tosakulwong N; Lesnick TG; Zuk SM; Gunter JL; Gleason CE; Wharton W; Dowling NM; Vemuri P; Senjem ML; Shuster LT; Bailey KR; Rocca WA; Jack CR; Asthana S; Miller VM
    Neurology; 2016 Aug; 87(9):887-96. PubMed ID: 27473135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early Postmenopausal Transdermal 17β-Estradiol Therapy and Amyloid-β Deposition.
    Kantarci K; Lowe VJ; Lesnick TG; Tosakulwong N; Bailey KR; Fields JA; Shuster LT; Zuk SM; Senjem ML; Mielke MM; Gleason C; Jack CR; Rocca WA; Miller VM
    J Alzheimers Dis; 2016 May; 53(2):547-56. PubMed ID: 27163830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain structure and cognition 3 years after the end of an early menopausal hormone therapy trial.
    Kantarci K; Tosakulwong N; Lesnick TG; Zuk SM; Lowe VJ; Fields JA; Gunter JL; Senjem ML; Settell ML; Gleason CE; Shuster LT; Bailey KR; Dowling NM; Asthana S; Jack CR; Rocca WA; Miller VM
    Neurology; 2018 Apr; 90(16):e1404-e1412. PubMed ID: 29661902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Oral vs Transdermal Estrogen Therapy on Sexual Function in Early Postmenopause: Ancillary Study of the Kronos Early Estrogen Prevention Study (KEEPS).
    Taylor HS; Tal A; Pal L; Li F; Black DM; Brinton EA; Budoff MJ; Cedars MI; Du W; Hodis HN; Lobo RA; Manson JE; Merriam GR; Miller VM; Naftolin F; Neal-Perry G; Santoro NF; Harman SM
    JAMA Intern Med; 2017 Oct; 177(10):1471-1479. PubMed ID: 28846767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Hormone Therapy on Cognition and Mood in Recently Postmenopausal Women: Findings from the Randomized, Controlled KEEPS-Cognitive and Affective Study.
    Gleason CE; Dowling NM; Wharton W; Manson JE; Miller VM; Atwood CS; Brinton EA; Cedars MI; Lobo RA; Merriam GR; Neal-Perry G; Santoro NF; Taylor HS; Black DM; Budoff MJ; Hodis HN; Naftolin F; Harman SM; Asthana S
    PLoS Med; 2015 Jun; 12(6):e1001833; discussion e1001833. PubMed ID: 26035291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of oral versus transdermal menopausal hormone treatments on self-reported sleep domains and their association with vasomotor symptoms in recently menopausal women enrolled in the Kronos Early Estrogen Prevention Study (KEEPS).
    Cintron D; Lahr BD; Bailey KR; Santoro N; Lloyd R; Manson JE; Neal-Perry G; Pal L; Taylor HS; Wharton W; Naftolin F; Harman SM; Miller VM
    Menopause; 2018 Feb; 25(2):145-153. PubMed ID: 28832429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal changes in menopausal symptoms comparing women randomized to low-dose oral conjugated estrogens or transdermal estradiol plus micronized progesterone versus placebo: the Kronos Early Estrogen Prevention Study.
    Santoro N; Allshouse A; Neal-Perry G; Pal L; Lobo RA; Naftolin F; Black DM; Brinton EA; Budoff MJ; Cedars MI; Dowling NM; Dunn M; Gleason CE; Hodis HN; Isaac B; Magnani M; Manson JE; Miller VM; Taylor HS; Wharton W; Wolff E; Zepeda V; Harman SM
    Menopause; 2017 Mar; 24(3):238-246. PubMed ID: 27779568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heart fat and carotid artery atherosclerosis progression in recently menopausal women: impact of menopausal hormone therapy: The KEEPS trial.
    El Khoudary SR; Venugopal V; Manson JE; Brooks MM; Santoro N; Black DM; Harman M; Naftolin F; Hodis HN; Brinton EA; Miller VM; Taylor HS; Budoff MJ
    Menopause; 2020 Mar; 27(3):255-262. PubMed ID: 32015261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of menopausal hormone formulations on pituitary-ovarian regulatory feedback.
    Kling JM; Dowling NM; Bimonte-Nelson HA; Gleason CE; Kantarci K; Manson JE; Taylor HS; Brinton EA; Lobo RA; Cedars MI; Pal L; Neal-Perry G; Naftolin F; Harman SM; Miller VM
    Am J Physiol Regul Integr Comp Physiol; 2019 Dec; 317(6):R912-R920. PubMed ID: 31663769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Menopausal hormone therapy, blood thrombogenicity, and development of white matter hyperintensities in women of the Kronos Early Estrogen Prevention Study.
    Jayachandran M; Lahr BD; Bailey KR; Miller VM; Kantarci K
    Menopause; 2020 Mar; 27(3):305-310. PubMed ID: 31934946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sleep quality and cortical amyloid-β deposition in postmenopausal women of the Kronos early estrogen prevention study.
    Zeydan B; Lowe VJ; Tosakulwong N; Lesnick TG; Senjem ML; Jack CR; Fields JA; James TT; Gleason CE; Dowling NM; Miller VM; Kantarci K
    Neuroreport; 2021 Mar; 32(4):326-331. PubMed ID: 33470769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lessons from KEEPS: the Kronos Early Estrogen Prevention Study.
    Miller VM; Taylor HS; Naftolin F; Manson JE; Gleason CE; Brinton EA; Kling JM; Cedars MI; Dowling NM; Kantarci K; Harman SM
    Climacteric; 2021 Apr; 24(2):139-145. PubMed ID: 32880220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of different hormone therapies on breast pain in recently postmenopausal women: findings from the Mayo Clinic KEEPS breast pain ancillary study.
    Files JA; Miller VM; Cha SS; Pruthi S
    J Womens Health (Larchmt); 2014 Oct; 23(10):801-5. PubMed ID: 25268853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postmenopausal hormone therapy and regional brain volumes: the WHIMS-MRI Study.
    Resnick SM; Espeland MA; Jaramillo SA; Hirsch C; Stefanick ML; Murray AM; Ockene J; Davatzikos C
    Neurology; 2009 Jan; 72(2):135-42. PubMed ID: 19139364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of estrogen with micronized progesterone on cortical and trabecular bone mass and microstructure in recently postmenopausal women.
    Farr JN; Khosla S; Miyabara Y; Miller VM; Kearns AE
    J Clin Endocrinol Metab; 2013 Feb; 98(2):E249-57. PubMed ID: 23322818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of estrogen and micronized progesterone or medroxyprogesterone acetate on cognition in postmenopausal women.
    Sherwin BB; Grigorova M
    Fertil Steril; 2011 Aug; 96(2):399-403. PubMed ID: 21703613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma orexin A levels in recently menopausal women during and 3 years following use of hormone therapy.
    Cintron D; Beckman JP; Bailey KR; Lahr BD; Jayachandran M; Miller VM
    Maturitas; 2017 May; 99():59-65. PubMed ID: 28364870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of hormones on skin wrinkles and rigidity vary by race/ethnicity: four-year follow-up from the ancillary skin study of the Kronos Early Estrogen Prevention Study.
    Owen CM; Pal L; Mumford SL; Freeman R; Isaac B; McDonald L; Santoro N; Taylor HS; Wolff EF
    Fertil Steril; 2016 Oct; 106(5):1170-1175.e3. PubMed ID: 27393520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Menopausal symptom experience before and after stopping estrogen therapy in the Women's Health Initiative randomized, placebo-controlled trial.
    Brunner RL; Aragaki A; Barnabei V; Cochrane BB; Gass M; Hendrix S; Lane D; Ockene J; Woods NF; Yasmeen S; Stefanick M
    Menopause; 2010; 17(5):946-54. PubMed ID: 20505547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of Hormone Therapy on Heart Fat and Coronary Artery Calcification Progression: Secondary Analysis From the KEEPS Trial.
    El Khoudary SR; Zhao Q; Venugopal V; Manson JE; Brooks MM; Santoro N; Black DM; Harman SM; Cedars MI; Hopkins PN; Kearns AE; Miller VM; Taylor HS; Budoff MJ
    J Am Heart Assoc; 2019 Aug; 8(15):e012763. PubMed ID: 31652073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.